210 related articles for article (PubMed ID: 34050578)
1. Comparison of Genomic Characterization in Upper Tract Urothelial Carcinoma and Urothelial Carcinoma of the Bladder.
Yang K; Yu W; Liu H; Ding F; Zhang Y; Zhang Y; Wang W; Lou F; Cao S; Wang H; He Z
Oncologist; 2021 Aug; 26(8):e1395-e1405. PubMed ID: 34050578
[TBL] [Abstract][Full Text] [Related]
2. Aristolochic acid-associated urinary tract cancers: an updated meta-analysis of risk and oncologic outcomes after surgery and systematic review of molecular alterations observed in human studies.
Kang YC; Chen MH; Lin CY; Lin CY; Chen YT
Ther Adv Drug Saf; 2021; 12():2042098621997727. PubMed ID: 33815744
[TBL] [Abstract][Full Text] [Related]
3. Genomic profiling of Chinese patients with urothelial carcinoma.
Yang B; Zhao X; Wan C; Ma X; Niu S; Guo A; Wang J; Wang J; Sun D; Jiao S
BMC Cancer; 2021 Feb; 21(1):162. PubMed ID: 33588785
[TBL] [Abstract][Full Text] [Related]
4. Molecular Characterization of Upper Tract Urothelial Carcinoma in the Era of Next-generation Sequencing: A Systematic Review of the Current Literature.
Hassler MR; Bray F; Catto JWF; Grollman AP; Hartmann A; Margulis V; Matin SF; Roupret M; Sfakianos JP; Shariat SF; Faltas BM
Eur Urol; 2020 Aug; 78(2):209-220. PubMed ID: 32571725
[TBL] [Abstract][Full Text] [Related]
5. Clinicopathological characteristics, molecular landscape, and biomarker landscape for predicting the efficacy of PD-1/PD-L1 inhibitors in Chinese population with mismatch repair deficient urothelial carcinoma: a real-world study.
Ma YT; Hua F; Zhong XM; Xue YJ; Li J; Nie YC; Zhang XD; Ma JW; Lin CH; Zhang HZ; He W; Sha D; Zhao MQ; Yao ZG
Front Immunol; 2023; 14():1269097. PubMed ID: 38022513
[TBL] [Abstract][Full Text] [Related]
6. Molecular profiles and urinary biomarkers of upper tract urothelial carcinomas associated with aristolochic acid exposure.
Karanović S; Ardin M; Tang Z; Tomić K; Villar S; Renard C; Venturini E; Lorch AH; Lee DS; Stipančić Ž; Slade N; Vuković Brinar I; Dittrich D; Karlović K; Borovečki F; Dickman KG; Olivier M; Grollman AP; Jelaković B; Zavadil J
Int J Cancer; 2022 Jan; 150(2):374-386. PubMed ID: 34569060
[TBL] [Abstract][Full Text] [Related]
7. The mutational pattern of homologous recombination repair genes in urothelial carcinoma and its correlation with immunotherapeutic response.
Chen J; Tang Y; Liu H; Sun G; Liu H; Zhao J; Wang Z; Zhang Y; Lou F; Cao S; Qin J; Wang H; Liao B; Zeng H
Cancer Med; 2023 Dec; 12(24):22370-22380. PubMed ID: 37986697
[TBL] [Abstract][Full Text] [Related]
8. A deep-learning workflow to predict upper tract urothelial carcinoma protein-based subtypes from H&E slides supporting the prioritization of patients for molecular testing.
Angeloni M; van Doeveren T; Lindner S; Volland P; Schmelmer J; Foersch S; Matek C; Stoehr R; Geppert CI; Heers H; Wach S; Taubert H; Sikic D; Wullich B; van Leenders GJ; Zaburdaev V; Eckstein M; Hartmann A; Boormans JL; Ferrazzi F; Bahlinger V
J Pathol Clin Res; 2024 Mar; 10(2):e12369. PubMed ID: 38504364
[TBL] [Abstract][Full Text] [Related]
9. Upper Tract Urothelial Carcinoma (UTUC): Prevalence, Impact and Management Challenge.
Nally E; Young M; Chauhan V; Wells C; Szabados B; Powles T; Jackson-Spence F
Cancer Manag Res; 2024; 16():467-475. PubMed ID: 38774494
[TBL] [Abstract][Full Text] [Related]
10. The evolution of metastatic upper tract urothelial carcinoma through genomic-transcriptomic and single-cell protein markers analysis.
Ohara K; Rendeiro AF; Bhinder B; Eng KW; Ravichandran H; Nguyen D; Pisapia D; Vosoughi A; Fernandez E; Shohdy KS; Manohar J; Beg S; Wilkes D; Robinson BD; Khani F; Bareja R; Tagawa ST; Ouseph MM; Sboner A; Elemento O; Faltas BM; Mosquera JM
Nat Commun; 2024 Mar; 15(1):2009. PubMed ID: 38499531
[TBL] [Abstract][Full Text] [Related]
11. Feasibility and tissue concordance of genomic sequencing of urinary cytology in upper tract urothelial carcinoma.
Katims AB; Gaffney C; Firouzi S; Yip W; Aulitzky A; Pietzak EJ; Donat SM; Bochner BH; Donahue TF; Herr HW; Dalbagni G; Al-Ahmadie H; Kim K; Solit DB; Lin O; Coleman JA
Urol Oncol; 2023 Oct; 41(10):433.e19-433.e24. PubMed ID: 37640571
[TBL] [Abstract][Full Text] [Related]
12. Clinical and Genomic Landscape of FGFR3-Altered Urothelial Carcinoma and Treatment Outcomes with Erdafitinib: A Real-World Experience.
Guercio BJ; Sarfaty M; Teo MY; Ratna N; Duzgol C; Funt SA; Lee CH; Aggen DH; Regazzi AM; Chen Z; Lattanzi M; Al-Ahmadie HA; Brannon AR; Shah R; Chu C; Lenis AT; Pietzak E; Bochner BH; Berger MF; Solit DB; Rosenberg JE; Bajorin DF; Iyer G
Clin Cancer Res; 2023 Nov; 29(22):4586-4595. PubMed ID: 37682528
[TBL] [Abstract][Full Text] [Related]
13. Downregulation of RNF128 Predicts Progression and Poor Prognosis in Patients with Urothelial Carcinoma of the Upper Tract and Urinary Bladder.
Lee YY; Wang CT; Huang SK; Wu WJ; Huang CN; Li CC; Chan TC; Liang PI; Hsing CH; Li CF
J Cancer; 2016; 7(15):2187-2196. PubMed ID: 27994654
[No Abstract] [Full Text] [Related]
14. Risk of secondary primary malignancies in survivors of upper tract urothelial carcinoma: A nationwide population-based analysis.
Wu KY; Cheong IS; Lai JN; Hu CY; Hung KC; Chen YT; Chiu LT; Tsai HT; Jou YC; Tzai TS; Tsai YS
Cancer Epidemiol; 2024 Apr; 89():102536. PubMed ID: 38281454
[TBL] [Abstract][Full Text] [Related]
15. Genomic characterization of response to chemoradiation in urothelial bladder cancer.
Desai NB; Scott SN; Zabor EC; Cha EK; Hreiki J; Sfakianos JP; Ramirez R; Bagrodia A; Rosenberg JE; Bajorin DF; Berger MF; Bochner BH; Zelefsky MJ; Kollmeier MA; Ostrovnaya I; Al-Ahmadie HA; Solit DB; Iyer G
Cancer; 2016 Dec; 122(23):3715-3723. PubMed ID: 27479538
[TBL] [Abstract][Full Text] [Related]
16.
Yu SH; Kim SS; Kim S; Lee H; Kang TW
J Clin Med; 2024 Feb; 13(5):. PubMed ID: 38592174
[No Abstract] [Full Text] [Related]
17. Comparison of European and American Guidelines for Upper Tract Urothelial Carcinoma: How Are They different?
Solano C; Corrales M; Keller EX; Kwok JL; Panthier F; Doizi S; Traxer O
J Endourol; 2024 May; 38(5):488-498. PubMed ID: 38429915
[TBL] [Abstract][Full Text] [Related]
18. Modeling biological and genetic diversity in upper tract urothelial carcinoma with patient derived xenografts.
Kim K; Hu W; Audenet F; Almassi N; Hanrahan AJ; Murray K; Bagrodia A; Wong N; Clinton TN; Dason S; Mohan V; Jebiwott S; Nagar K; Gao J; Penson A; Hughes C; Gordon B; Chen Z; Dong Y; Watson PA; Alvim R; Elzein A; Gao SP; Cocco E; Santin AD; Ostrovnaya I; Hsieh JJ; Sagi I; Pietzak EJ; Hakimi AA; Rosenberg JE; Iyer G; Vargas HA; Scaltriti M; Al-Ahmadie H; Solit DB; Coleman JA
Nat Commun; 2020 Apr; 11(1):1975. PubMed ID: 32332851
[TBL] [Abstract][Full Text] [Related]
19. Management of Upper Tract Urothelial Carcinoma in a Double Collecting System Kidney.
Zohar Y; Sivan B; Mintz I; Hefer B; Rouvinov K; Shani Shrem N; Mabjeesh NJ
J Pers Med; 2024 Jan; 14(2):. PubMed ID: 38392591
[TBL] [Abstract][Full Text] [Related]
20. Racial and sex differences in tumor genomics in urothelial carcinoma.
Nyame YA; Baker KK; Montgomery B; Grivas P; Redman MW; Wright JL
Urol Oncol; 2023 Nov; 41(11):456.e1-456.e5. PubMed ID: 37481462
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]
